World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
46
Citations
8884
World Ranking
4606
National Ranking
181

Debbie van Baarle publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Debbie van Baarle sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 198 publications — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Debbie van Baarle D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Debbie van Baarle sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 46 D-Index — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Debbie van Baarle is affiliated with the University Medical Center Groningen in the Netherlands. Their research primarily focuses on medicine and immunology and microbiology, with a particular emphasis on infectious diseases, immunology, epidemiology, molecular biology, and health.

Their work covers several key research topics, including:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • T-cell and B-cell Immunology
  • Influenza Virus Research Studies
  • Immune Cell Function and Interaction
  • Vaccine Coverage and Hesitancy
  • Immunotherapy and Immune Responses

Among the recent papers co-authored by van Baarle are:

  • The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant, 2021, Transplantation
  • The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant., 2022, PubMed
  • Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming, 2022, New England Journal of Medicine
  • Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial, 2022, The Lancet Infectious Diseases
  • COVID-19 vaccination: the VOICE for patients with cancer, 2021, Nature Medicine

Their frequent co-authors include:

  • Corine H. GeurtsvanKessel
  • Nynke Y. Rots
  • Rory D. de Vries
  • Marieke van der Heiden
  • Daryl Geers

Van Baarle has published extensively in several venues, often contributing to:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Immunology
  • Aging Cell
  • SSRN Electronic Journal
  • The Journal of Immunology

In addition to journal articles, van Baarle has contributed to book publications, including a work published by University of Groningen Press titled Wie de schoen past...: op weg naar vaccinaties op maat in 2023.

Best Publications

  • HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors

    Stephen A. Migueles;Alisha C. Laborico;W. Lesley Shupert;M. Shirin Sabbaghian

  • VDJdb: a curated database of T-cell receptor sequences with known antigen specificity

    Mikhail Shugay;Dmitriy V Bagaev;Ivan V Zvyagin;Renske M Vroomans

  • T cell responses to viral infections - opportunities for Peptide vaccination.

    Sietske Rosendahl Huber;Josine van Beek;Jørgen de Jonge;Willem Luytjes

  • Persistent numbers of tetramer+ CD8(+) T cells, but loss of interferon-gamma+ HIV-specific T cells during progression to AIDS.

    Stefan Kostense;Kristin Vandenberghe;Jeanine Joling;Debbie Van Baarle

  • Dysfunctional Epstein-Barr virus (EBV)-specific CD8(+) T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma.

    D. van Baarle;E. Hovenkamp;M.F.C. Callan;K.C. Wolthers

  • Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming

    Unknown

  • Impaired recovery of Epstein-Barr virus (EBV)--specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease

    Pauline Meij;Joost W J van Esser;Hubert G M Niesters;Debbie van Baarle

  • The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.

    Jan-Stephan F Sanders;Frederike J Bemelman;A Lianne Messchendorp;Carla C Baan

  • Failing immune control as a result of impaired CD8+ T-cell maturation: CD27 might provide a clue.

    Debbie van Baarle;Stefan Kostense;Marinus H.J. van Oers;Dorte Hamann

  • Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes

    Adrianus C. M. Boon;Gerrie de Mutsert;Debbie van Baarle;Derek J. Smith;Derek J. Smith

  • RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response

    Adam Penn-Nicholson;Stanley Kimbung Mbandi;Ethan Thompson;Simon C Mendelsohn

  • Metabolite changes in blood predict the onset of tuberculosis

    January rd Weiner;Jeroen Maertzdorf;Jayne S. Sutherland;Fergal J. Duffy

  • Changes in the composition of circulating CD8+ T cell subsets during acute Epstein-Barr and human immunodeficiency virus infections in humans

    M.T.L. Roos;R.A.W. van Lier;D. Hamann;G.J. Knol

  • Human Herpes Virus 6 Plasma DNA Positivity after Hematopoietic Stem Cell Transplantation in Children: an Important Risk Factor for Clinical Outcome

    P.J. Anne de Pagter;Rob Schuurman;Henk Visscher;Machiel de Vos

  • Cytomegalovirus persistence and T-cell immunosenescence in people aged fifty and older : A systematic review

    Marlies Weltevrede;Renske Eilers;Hester E. de Melker;Debbie van Baarle

  • Viral Replication Capacity as a Correlate of HLA B57/B5801-Associated Nonprogressive HIV-1 Infection

    Marjon Navis;Ingrid Schellens;Debbie van Baarle;José Borghans

  • Female sex and IL28B, a synergism for spontaneous viral clearance in hepatitis C virus (HCV) seroconverters from a community-based cohort

    Charlotte H. B. S. van den Berg;Bart P. X. Grady;Janke Schinkel;Thijs van de Laar

  • Significance of senescence for virus-specific memory T cell responses: rapid ageing during chronic stimulation of the immune system

    Debbie van Baarle;Aster Tsegaye;Frank Miedema;Arne Akbar

  • Immune activation and collateral damage in AIDS pathogenesis

    Frank Miedema;Mette D. Hazenberg;Kiki Tesselaar;Debbie van Baarle

  • T cell subset and cytokine profiles in human visceral leishmaniasis during active and asymptomatic or sub-clinical infection with Leishmania donovani.

    Asrat Hailu;Asrat Hailu;Debbie van Baarle;Gerlinde J. Knol;Nega Berhe

  • The hallmarks of CMV-specific CD8 T-cell differentiation

    Sara P. H. van den Berg;Iris N. Pardieck;Josien Lanfermeijer;Delphine Sauce

  • Lack of Epstein-Barr virus- and HIV-specific CD27- CD8+ T cells is associated with progression to viral disease in HIV-infection

    Debbie van Baarle;Stefan Kostense;Egbert Hovenkamp;Graham Ogg

  • Immunophenotyping of blood lymphocytes at birth, during childhood, and during adulthood in HIV-1-uninfected Ethiopians.

    Aster Tsegaye;Dawit Wolday;Sigrid Otto;Beyene Petros

  • Loss of EBNA1-specific memory CD4+ and CD8+ T cells in HIV-infected patients progressing to AIDS-related non-hodgkin lymphoma

    Erwan Piriou;Karel van Dort;Karel van Dort;Nening M. Nanlohy;Nening M. Nanlohy;Marinus H. J. van Oers;Marinus H. J. van Oers

  • mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial.

    Sjoukje F Oosting;Astrid A M van der Veldt;Corine H GeurtsvanKessel;Rudolf S N Fehrmann

Frequent Co-Authors

Frank Miedema
Frank Miedema Utrecht University
Andy I. M. Hoepelman
Andy I. M. Hoepelman Utrecht University
Hanneke Schuitemaker
Hanneke Schuitemaker Valneva (Austria)
Joep M. A. Lange
Joep M. A. Lange University of Amsterdam
Rob Schuurman
Rob Schuurman Utrecht University
Elisabeth A. M. Sanders
Elisabeth A. M. Sanders Utrecht University
David Price
David Price University of Aberdeen
Tom H. M. Ottenhoff
Tom H. M. Ottenhoff Leiden University Medical Center
John J. Miles
John J. Miles James Cook University
Neeltje A. Kootstra
Neeltje A. Kootstra University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related healthcare degrees can open diverse career pathways. Nursing programs, particularly Licensed Practical Nurse (LPN) and Nurse Practitioner (NP) degrees, offer foundational and advanced clinical skills applicable in immunological research and patient care. Students seeking flexible options might consider the easiest LPN programs to get into, which provide accessible entry points into nursing.

Advancing further, prospective students often look for the what is the easiest NP program to balance rigorous study with manageable coursework. Specializing in psychiatric and mental health nursing can also intersect with immunology, particularly through mind-body health connections. The best psychiatric mental health nurse practitioner programs online ensure strong clinical opportunities, vital for hands-on experience.

Affordability is another key consideration. Students aiming to minimize costs without sacrificing quality may explore the cheapest online PMHNP programs. These programs maintain strong accreditation and clinical standards while easing financial burdens, facilitating access to important healthcare roles connected to immunological research and practice.

Best Scientists Citing Debbie van Baarle

Trending Scientists